Banque d'échantillons biologiques et de données (cliniques et socio-démographiques) associées à des fins de recherche sur le cancer de la prostate.
Biobanque procure
 Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Prostate |
Dr. Michel Carmel
Elsie Morneau
819-346-1110 poste 12827
|
RADICAL PC1 : The Role of Androgen Deprivation Therapy in Cardiovascular Disease – A Longitudinal Prostate Cancer Study.
RADICAL PC2 : A randomized Intervention for cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients.
RADICAL PC
NCT03127631
Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Prostate |
Dr. Robert Sabbagh
Elsie Morneau
819-346-1110 poste 12827
|
The Role of Therapeutic Layering of Stereotactic Body Radiotherapy on Darolutamide in the Management of Oligoprogressive Castration Resistant Prostate Cancer: A Pilot Phase II Trial
PCS X
NCT04070209
Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Prostate |
Dr. Audrey Tétreault-Laflamme
Cynthia Ladouceur
819-346-1110 poste 13250
|
Pelvic Nodes Ultra-Hypo Fractionated Versus Conventionally Fractionated IMRT With HDR Brachytherapy Boost in Prostate Cancer: A Collaborative Multi-institutional Non-inferiority Phase 3 Trial.
PCS-XI
NCT05820633
Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Prostate |
Dr. Annie Ebacher
Patricia Roy
819-346-1110 poste 14082
|
Parallel Phase III Randomized Trials of Genomic-Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation
GUIDANCE
NCT05050084
Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Prostate |
Dr. Annie Ebacher
Patricia Roy
819-346-1110 poste 14082
|
Detection and Monitoring of Metastasis by 18F-DCFPyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer and Negative Conventional Imaging
PROSTEP-002
NCT04655365
Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Prostate |
Dr. Robert Sabbagh
Elsie Morneau
819-346-1110 poste 12827
|
A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Darolutamide Plus Androgen Deprivation Therapy (ADT) Compared With Placebo Plus ADT in Patients With High-risk Biochemical Recurrence (BCR) of Prostate Cancer
ARASTEP
NCT05794906
Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Prostate |
Dr. Audrey Tétreault-Laflamme
Patricia Roy
819-346-1110 poste 14082
|
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation
PREDICT-RT*
NCT04513717
Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Prostate |
Dr. Audrey Tétreault-Laflamme
Patricia Roy
819-346-1110 poste 14082
|
Groupe d'étude en oncologie du Québec